Get the Stockscreener App
0.3701
2.96%
-0.0113
After Hours:
.37
-0.000100
-0.03%
Adial Pharmaceuticals Inc stock is traded at $0.3701, with a volume of 306.47K.
It is down -2.96% in the last 24 hours and up +5.74% over the past month.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
See More
Previous Close:
$0.3814
Open:
$0.3742
24h Volume:
306.47K
Relative Volume:
0.18
Market Cap:
$8.08M
Revenue:
-
Net Income/Loss:
$-6.07M
P/E Ratio:
-0.064
EPS:
-5.78
Net Cash Flow:
$-7.34M
1W Performance:
-7.82%
1M Performance:
+5.74%
6M Performance:
-47.87%
1Y Performance:
-61.04%
1-Day Range:
$0.365
$0.38
1-Week Range:
$0.364
$0.43
52-Week Range:
$0.22
$1.30
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Name
Adial Pharmaceuticals Inc
Sector
Industry
Phone
434-422-9800
Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
0.3701 | 8.33M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-18 | Initiated | Maxim Group | Buy |
| Oct-11-18 | Initiated | Dawson James | Buy |
Adial Pharmaceuticals Inc Stock (ADIL) Latest News
Can Adial Pharmaceuticals Inc. stock withstand economic slowdownTrade Entry Report & AI Forecasted Stock Moves - newser.com
Will Adial Pharmaceuticals Inc. stock continue upward momentumTrade Entry Summary & Reliable Volume Spike Trade Alerts - newser.com
Should I hold or sell Adial Pharmaceuticals Inc. stock in 20252025 Technical Overview & Weekly Watchlist for Hot Stocks - newser.com
Relative strength of Adial Pharmaceuticals Inc. in sector analysisJuly 2025 Review & Daily Technical Forecast Reports - newser.com
Using R and stats models for Adial Pharmaceuticals Inc. forecastingJuly 2025 Movers & Weekly Chart Analysis and Guides - newser.com
Will Adial Pharmaceuticals Inc. stock benefit from infrastructure spending2025 Technical Patterns & Entry and Exit Point Strategies - newser.com
Adial completes key validation for alcohol disorder treatment test By Investing.com - Investing.com Nigeria
Adial completes key validation for alcohol disorder treatment test - Investing.com
Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution - GlobeNewswire
100% SNP concordance: Adial and Genomind validate cheek‑swab test for AD04; AG+ biomarker ~14% - Stock Titan
Top chart patterns to watch in Adial Pharmaceuticals Inc.Gap Up & Smart Investment Allocation Insights - newser.com
Will Adial Pharmaceuticals Inc. benefit from macro trendsWeekly Earnings Recap & Real-Time Volume Trigger Notifications - newser.com
Nxera Pharma (OTCMKTS:SOLTF) and Adial Pharmaceuticals (NASDAQ:ADIL) Head to Head Survey - Defense World
Why Adial Pharmaceuticals Inc. stock is a must watch in 2025Weekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
What recovery options are there for Adial Pharmaceuticals Inc.July 2025 Gainers & Comprehensive Market Scan Reports - newser.com
Should you hold or exit Adial Pharmaceuticals Inc. nowJuly 2025 Update & AI Driven Stock Reports - newser.com
How moving averages guide Adial Pharmaceuticals Inc. tradingMarket Weekly Review & Daily Volume Surge Signals - newser.com
Maxim Group Upgrades Adial Pharmaceuticals (ADIL) - Nasdaq
This Semtech Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
What drives Adial Pharmaceuticals Inc stock priceLong-Term Growth Stocks & High Profit Trading Signals - earlytimes.in
Adial Pharmaceuticals (ADIL) Upgraded by Maxim Group | ADIL Stoc - GuruFocus
Is Adial Pharmaceuticals Inc affected by consumer sentimentWeekly Earnings Recap & Daily Growth Stock Tips - خودرو بانک
Dividend Watch: Is The First of Long Island Corporation showing insider buyingEntry Point & Real-Time Buy Zone Alerts - khodrobank.com
Is Adial Pharmaceuticals Inc. stock bottoming outWatch List & Fast Moving Stock Trade Plans - newser.com
Why Adial Pharmaceuticals Inc. is moving todayMarket Performance Report & Free Real-Time Volume Trigger Notifications - newser.com
Layoff Watch: Is Adial Pharmaceuticals Inc affected by consumer sentimentEarnings Beat & Growth Focused Stock Pick Reports - khodrobank.com
New Highs: What are Adial Pharmaceuticals Incs technical support levelsWeekly Risk Summary & Fast Entry and Exit Trade Plans - khodrobank.com
RSI Check: Can Adial Pharmaceuticals Inc weather a recessionJuly 2025 Macro Moves & Fast Gain Swing Alerts - خودرو بانک
Insider Buy: Will Canadian Solar Inc benefit from green energy policiesJuly 2025 Spike Watch & Low Volatility Stock Suggestions - khodrobank.com
What MACD and RSI say about Adial Pharmaceuticals Inc.Quarterly Risk Review & Weekly Return Optimization Alerts - newser.com
Profit Recap: Why is UMBF stock going up2025 Top Gainers & Safe Investment Capital Preservation Plans - خودرو بانک
Stock Market Recap: How correlated is Nixxy Inc to the S P500Weekly Trade Summary & Growth Focused Stock Pick Reports - khodrobank.com
Adial Pharmaceuticals Inc Stock (ADIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):